Low arginine vasopressin levels in patients with diabetes insipidus are not associated with anaemia.

Autor: Winzeler B; Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Morin B; Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Refardt J; Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Imber C; Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Fenske W; Department of Endocrinology and Nephrology, University of Leipzig, Leipzig, Germany.; Leipzig University Medical Centre, IFB Adiposity Diseases, Leipzig, Germany., Sailer CO; Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland., Holbro A; Department of Haematology, University Hospital Basel, Switzerland., Christ-Crain M; Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Switzerland.; Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland.
Jazyk: angličtina
Zdroj: Clinical endocrinology [Clin Endocrinol (Oxf)] 2020 Oct; Vol. 93 (4), pp. 456-465. Date of Electronic Publication: 2020 Jul 13.
DOI: 10.1111/cen.14265
Abstrakt: Objective: Arginine vasopressin (AVP) is released upon osmotic stimulation or hypovolaemia in order to maintain water balance. A recent study showed a role of AVP in haematopoiesis by stimulating red blood cell precursors, suggesting a higher risk of anaemia in patients with AVP deficiency. The objective was to explore the effect of low AVP levels in patients with central diabetes insipidus (cDI) and primary polydipsia (PP) on haemoglobin and the prevalence of anaemia.
Methods: A total of 164 patients with either cDI (70, 43%) or PP (94, 57%) and 30 healthy volunteers from two prospective diagnostic studies performed in Switzerland, Germany and Brazil were studied. A standardized clinical and biochemical (eg copeptin, full blood count) assessment was performed. Haemoglobin and haematocrit levels and prevalence of anaemia (defined as haemoglobin values of <120 g/L in women and <130 g/L in men) were analysed.
Results: Mean copeptin values were 2.63 pmol/L (±1.08) and 3.91 pmol/L (±4.28) in patients with cDI and PP and 24.76 pmol/L (±5.75) in healthy volunteers, P = .02. The prevalence of anaemia was low in all participants with 7.1%, 2.2% and 10% in cDI, PP and in healthy volunteers, P = .15. Mean haemoglobin values were similar in all groups: 139 g/L (±15.85), 140 g/L (±13.16) and 139 g/L (±13.05) in patients with cDI, PP and healthy volunteers, P = .90, as were mean haematocrit values with 41% in all groups (P = .85).
Conclusion: Chronic low AVP levels in patients with cDI and PP do not affect haemoglobin levels and prevalence of anaemia.
(© 2020 John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz: